BioVentures MedTech Funds

BioVentures is a US-based venture firm that backs clinicians and inventors building medical devices and diagnostics with a clear thesis around reducing total cost of care. The fund partners with operators who have a procedural or diagnostic insight that can shorten care episodes, displace more expensive interventions, or move care to lower-cost settings. They are not an AI-first investor — the focus is on devices and diagnostics, where AI may be embedded but is rarely the headline.

BioVentures invests at Series A, Series B, and growth stages with check sizes between $5M and $25M. That makes them a candidate for lead or substantial co-investor positions in mid-stage MedTech rounds where reimbursement strategy and clinical evidence are already maturing. The team operates across the US device and diagnostics ecosystem rather than from a single regional cluster.

Founders should approach BioVentures when the value proposition is grounded in measurable cost reduction — fewer hospitalizations, shorter procedures, earlier diagnosis that prevents downstream spend — and when there is a clear reimbursement and commercialization path. Early prototypes without clinical data or pure software plays are unlikely to land. The firm’s clinical-innovator orientation means founders with strong physician co-founders or KOL relationships will get more traction than purely engineering-led teams. Come prepared with a unit-economics story that a payer or hospital CFO would recognize.